What are the Benefits of Zydus Cadila's Newly Approved ZyCov-D Vaccine
Zycov-D is developed by Zydus Cadila and it has been approved for emergency use for Covid-19 in India. India has already approved 5 vaccines and now ZyCov-D is also approved for emergency use in India. ZyCov-D has been tested and can be given to children and adults 12 years and above. Zydus Cadila has approved Zycov-D vaccine for Phase III clinical trials under the Department of Biotebiotechnology by the Drug Controller General of India (DCGI) in Zydus Cadila. Cadila Healthcare will begin the Phase II trials of the vaccine candidate on August 6, 2021, as part of an adaptive multicentre dose increase in phase I / II using randomized, placebo-controlled methods. The company also confirmed that a second candidate vaccine, ZycoV-MV, targeting COVID-19, has completed pragmatic clinical trials in non-human primate immunogenicity studies and will be presented shortly. Key Pointers about ZyCov-D Vaccine: ZyCov-D is the world’s first Plasmid DNA Vaccine for Covid-19 ZyCov-D Vaccine ...